Keyuan Industry Fund logo

Keyuan Industry Fund

Asia, Beijing, China, Beijing

Description

Keyuan Industry Fund is a fund manager that focuses on integrating technological innovation, financial support, and industrial resources.

Investor Profile

Keyuan Industry Fund has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (50%)
  • Series Unknown (25%)
  • Series A (25%)

Country Focus

  • China (75%)
  • United States (25%)

Industry Focus

  • Biotechnology
  • Manufacturing
  • Genetics
  • Life Science
  • Recycling
  • Chemical
  • Cleantech
  • Biopharma
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Keyuan Industry Fund frequently co-invest with?

New Frontier Health
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Co-Investments: 1
DC
North America, Arizona, United States, Scottsdale
Co-Investments: 1
Linden Asset
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Jinyi Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Innolink Fund
Asia, Beijing, China, Haidian
Co-Investments: 1
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 1
IMO Ventures
North America, California, United States, San Mateo
Co-Investments: 1
Chimera Investment
Asia, Abu Dhabi, United Arab Emirates, Abu Dhabi
Co-Investments: 1
MF
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Keyuan Industry Fund?

Phase Two Chemicals

Lowell, Massachusetts, United States

Phase Two Chemicals is a clean chemistry company developing breakthrough technology for on-site hydrogen peroxide production.

ChemicalCleanTechManufacturing
Series AJan 1, 2022
Amount Raised: $12,000,000
Abogen Biosciences

Suzhou, Jiangsu, China

Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.

BiotechnologyGeneticsLife Science
Series CNov 29, 2021
Amount Raised: $300,000,000
ESSE

Beijing, Beijing, China

ESSE specializes in the production of environmentally functional materials using industrial solid waste recycling technology.

ManufacturingRecycling
Series UnknownNov 1, 2021
Elpiscience Biopharmaceuticals

Shanghai, Shanghai, China

Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies

BiopharmaBiotechnologyHealth CarePharmaceutical
Series CMay 13, 2021
Amount Raised: $105,000,000